August 5, 2021

Synedgen Initiates Clinical Trial Assessing Combination of SynePure and Catasyn for the Treatment of Partial Thickness Burns
Read More

February 18, 2021

Synedgen Appoints Industry Veteran Dennis Fenton, Ph.D., to Board of Directors
Read More

December 10, 2020

Synedgen Partnership with the University of New South Wales Receives Australian Research Council (ARC) Grant
Read More